Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDs Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
Atopic Dermatitis: New Topical Agent, Durable Results With Orals Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
First-Ever Positive Phase III Trial in Epidermolysis Bullosa Faster wound healing with oleogel-S10, particularly in most common form of EB Nov 01, 2020
Add Skin Conditions to COVID-19 Long-Hauler Effects Persistence beyond 60 days in some cases, especially with pernio/chilblains Oct 30, 2020
Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Combo Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
Demographics Make a Difference in Common Skin Cancers Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
Calcineurin Blockers for Eczema: No Cancer Signal in Big Study "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
New Insights Into Radiation-Induced Hair Loss Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
Skin Rashes a Clue to COVID-19 Vascular Disease Certain skin manifestations tied to coagulopathy in the sickest patients Aug 05, 2020
Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
DPP-4 Inhibitors Tied to Blistering Skin Condition Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
Targeting IL-23 Relieves Multiple Symptoms in PsA Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
COVID-19 May Manifest in the Mouth in Some Patients Pay attention to those with a rash, small case series from Spain advises Jul 15, 2020
Psoriasis Cream Succeeds in Early Trial PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020
Audio-Only Telemedicine: Docs Say Payment Falls Short Clinicians wonder why the technology used, not a virtual visit's content or complexity, dictates reimbursement Jul 13, 2020
Sobering Data on Risks of Short-Term Oral Corticosteroids Short steroid bursts linked to serious adverse events within a month Jul 06, 2020
Minimal Link Between Eczema and Most Cancers Study finds severe eczema tied to small risk for lymphoma Jun 30, 2020
Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
Once-Daily Abrocitinib Succeeds for Atopic Dermatitis Oral treatment acts as JAK inhibitor Jun 05, 2020
EULAR 2020: What to Expect Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
Face-Aging Selfies Help Modify Risky Skin Behaviors for Teens Trial looked at effects of a free "UV-selfie" app May 07, 2020
6-Week Keytruda Safe, Effective in Melanoma Schedule gets FDA approval for all adult indications Apr 30, 2020
Hidradenitis Suppurativa Closely Linked with Childhood Weight Prevalence of the painful skin condition will likely increase with rising childhood obesity rates, Danish researchers say Apr 30, 2020
Derm Residents Protest Board's In-Person Certification Exam Must travel to Florida in July for required test Apr 28, 2020
Triplet Succeeds in BRAF-Mutant Melanoma Immunotherapy plus BRAF/MEK inhibition boosts PFS over targeted agents alone Apr 27, 2020
Guselkumab a Hit in Phase III for PsA Primary endpoints met in two large trials in psoriatic arthritis for IL-23 inhibitor Apr 10, 2020
Psoriasis IL-23 Biologic Maintains Efficacy in 2-Year Trial Phase III trial looked at risankizumab (Skyrizi) Apr 08, 2020
How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really? Real-world data offer word of caution for oncologists Apr 01, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
Phase II Success for Oral CKD-Related Pruritus Agent Novel drug activates kappa opioid receptors Mar 27, 2020
No Major Pregnancy Problems Seen With Antifungal Derm Drug But caution urged nonetheless Mar 04, 2020
IL-31 Drug Succeeds for Prurigo Nodularis Less itching and twice as many lesions resolved with investigational agent Feb 19, 2020
Staving Off Sepsis; Bleeding and Fibroids: It's Double T Healthwatch! This week's topics also include blood levels of sunscreen ingredients, and fish oil and sperm quality Jan 25, 2020 podcast
'Surprising' Number of Cancer Survivors Use Alcohol Clinicians urged to step up alcohol screening at regular intervals, intervention Jan 22, 2020
What Is Causing This Woman's Swollen Chin? A long and challenging diagnostic path with twists and turns Jan 20, 2020
Cancer Drug Helpful for Children With Olmsted Syndrome Two small case series show rapid remission of nonmalignant keratinocyte proliferation Jan 02, 2020
Confirmed: TNF Inhibitors Don't Raise Cancer Risk Reassurance from national study in Denmark Dec 13, 2019
